How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

248 results for

Tinea Corporis

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

21. Efficacy and safety of oral fluconazole in the treatment of patients with tinea corporis, cruris or pedis or cutaneous candidosis : a multicentre, open, noncomparative study. (PubMed)

Efficacy and safety of oral fluconazole in the treatment of patients with tinea corporis, cruris or pedis or cutaneous candidosis : a multicentre, open, noncomparative study. The efficacy, safety, required duration of treatment, and patient preference for oral fluconazole 150 mg/week in the treatment of 521 patients with cutaneous candidosis, tinea corporis, tinea cruris or tinea pedis were assessed in an open, multicentre, noncomparative trial. Patients received weekly doses of fluconazole (...) effective in the treatment of tinea corporis, tinea cruris, tinea pedis and cutaneous candidosis. Furthermore, there was a high patient preference for oral fluconazole over previous topical therapy.

2014 Clinical drug investigation

22. An Open Label Pharmacokinetic Study of Naftin for Tinea Corporis

An Open Label Pharmacokinetic Study of Naftin for Tinea Corporis An Open Label Pharmacokinetic Study of Naftin for Tinea Corporis - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. An Open Label (...) Pharmacokinetic Study of Naftin for Tinea Corporis The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02466867 Recruitment Status : Completed First Posted : June 9, 2015 Last Update Posted : October 28, 2016 Sponsor: Merz North America, Inc. Information provided by (Responsible Party): Merz North America, Inc

2014 Clinical Trials

23. Pediatric Subjects With Tinea Corporis

Pediatric Subjects With Tinea Corporis Pediatric Subjects With Tinea Corporis - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Pediatric Subjects With Tinea Corporis The safety and scientific validity (...) how well the study cream works when applied once a day to affected area of child (where they have ringworm). The results will be compared to those seen with a placebo cream which has no active ingredient. Safety of the cream will also be measured. Condition or disease Intervention/treatment Phase Tinea Corporis Drug: Naftin Cream Drug: Placebo Cream Phase 4 Detailed Description: The objectives of this study are to evaluate the safety and efficacy of Naftin (naftifine hydrochloride) Cream, 2

2014 Clinical Trials

24. Tinea Corporis (Treatment)

Tinea Corporis (Treatment) Tinea Corporis Treatment & Management: Medical Care, Surgical Care, Complications Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTA5MTQ3My10cmVhdG1lbnQ= processing > Tinea Corporis (...) Treatment & Management Updated: Jul 10, 2018 Author: Jack L Lesher, Jr, MD; Chief Editor: Dirk M Elston, MD Share Email Print Feedback Close Sections Sections Tinea Corporis Treatment Medical Care Topical therapy is recommended for a localized infection because dermatophytes rarely invade living tissues. Topical therapy should be applied to the lesion and at least 2 cm beyond this area once or twice a day for at least 2 weeks, depending on which agent is used. [ ] Topical azoles and allylamines show

2014 eMedicine.com

25. Tinea Corporis (Overview)

Tinea Corporis (Overview) Tinea Corporis: Practice Essentials, Background, Pathophysiology Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTA5MTQ3My1vdmVydmlldw== processing > Tinea Corporis Updated: Jul 10, 2018 (...) Author: Jack L Lesher, Jr, MD; Chief Editor: Dirk M Elston, MD Share Email Print Feedback Close Sections Sections Tinea Corporis Overview Practice Essentials Tinea corporis is a superficial dermatophyte infection characterized by either inflammatory or noninflammatory lesions on the glabrous skin (ie, skin regions other than the scalp, groin, palms, and soles). [ ] Three anamorphic (asexual or imperfect) genera cause dermatophytoses: Trichophyton , Microsporum , and Epidermophyton . Dermatophytes may

2014 eMedicine.com

26. Tinea Corporis (Follow-up)

Tinea Corporis (Follow-up) Tinea Corporis Treatment & Management: Medical Care, Surgical Care, Complications Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTA5MTQ3My10cmVhdG1lbnQ= processing > Tinea Corporis (...) Treatment & Management Updated: Jul 10, 2018 Author: Jack L Lesher, Jr, MD; Chief Editor: Dirk M Elston, MD Share Email Print Feedback Close Sections Sections Tinea Corporis Treatment Medical Care Topical therapy is recommended for a localized infection because dermatophytes rarely invade living tissues. Topical therapy should be applied to the lesion and at least 2 cm beyond this area once or twice a day for at least 2 weeks, depending on which agent is used. [ ] Topical azoles and allylamines show

2014 eMedicine.com

27. Tinea Corporis (Diagnosis)

Tinea Corporis (Diagnosis) Tinea Corporis: Practice Essentials, Background, Pathophysiology Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTA5MTQ3My1vdmVydmlldw== processing > Tinea Corporis Updated: Jul 10, 2018 (...) Author: Jack L Lesher, Jr, MD; Chief Editor: Dirk M Elston, MD Share Email Print Feedback Close Sections Sections Tinea Corporis Overview Practice Essentials Tinea corporis is a superficial dermatophyte infection characterized by either inflammatory or noninflammatory lesions on the glabrous skin (ie, skin regions other than the scalp, groin, palms, and soles). [ ] Three anamorphic (asexual or imperfect) genera cause dermatophytoses: Trichophyton , Microsporum , and Epidermophyton . Dermatophytes may

2014 eMedicine.com

28. Efficacy and Safety of Terbinafine Hydrochloride 1% Cream vs. Sertaconazole Nitrate 2% Cream in Tinea Corporis and Tinea Cruris: A Comparative Therapeutic Trial. (Full text)

Efficacy and Safety of Terbinafine Hydrochloride 1% Cream vs. Sertaconazole Nitrate 2% Cream in Tinea Corporis and Tinea Cruris: A Comparative Therapeutic Trial. To the best of our knowledge, till date no study comparing the efficacy and safety of terbinafine hydrochloride 1% cream and sertaconazole nitrate 2% cream has been done in localized tinea corporis and tinea cruris.This clinical trial was carried out to study and compare the efficacy of topical terbinafine hydrochloride 1% cream (...) and sertaconazole nitrate 2% cream in localized tinea corporis and tinea cruris and to know the adverse effects of these antifungal creams.In this prospective, single blind, randomized control trial with two arms, patient were randomized into two groups Group A (treatment with terbinafine cream) and Group B (treatment with sertaconazole cream). A total of 38 patients were enrolled for the study, 20 patients in group A and 18 patients in group B. But five patients of group A and three patients of group B were

2013 Indian journal of dermatology PubMed

29. Safety of a Topical Antifungal Treatment for Tinea Cruris, Tinea Pedis and Tinea Corporis

Safety of a Topical Antifungal Treatment for Tinea Cruris, Tinea Pedis and Tinea Corporis Safety of a Topical Antifungal Treatment for Tinea Cruris, Tinea Pedis and Tinea Corporis - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more (...) studies before adding more. Safety of a Topical Antifungal Treatment for Tinea Cruris, Tinea Pedis and Tinea Corporis The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01349998 Recruitment Status : Completed First Posted : May 9, 2011 Last Update Posted : January 29, 2013 Sponsor: Tinea Pharmaceuticals

2011 Clinical Trials

30. Short-term therapy with luliconazole, a novel topical antifungal imidazole, in guinea pig models of tinea corporis and tinea pedis. (Full text)

Short-term therapy with luliconazole, a novel topical antifungal imidazole, in guinea pig models of tinea corporis and tinea pedis. Luliconazole is a novel topical antifungal imidazole with broad-spectrum and potent antifungal activity. The drug is under clinical development in the United States for management of dermatophytosis with a short-term treatment regimen. The present study was undertaken to investigate the clinical benefit of short-term therapy with luliconazole cream in guinea pig (...) models of tinea corporis and tinea pedis induced with Trichophyton mentagrophytes. The dose-dependent therapeutic efficacy of topical luliconazole cream (0.02 to 1%), measured by macroscopic improvement of skin lesions and by fungal eradication as determined by a culture assay, was demonstrated using a tinea corporis model. The improvement in skin lesions seen with luliconazole cream was observed even at a concentration of 0.02%, and its efficacy at 0.1% was equal to that of 1% bifonazole cream

2012 Antimicrobial Agents and Chemotherapy PubMed

31. Tinea corporis in a mixed martial arts fighter (Full text)

Tinea corporis in a mixed martial arts fighter 23109614 2013 09 23 2018 11 13 1488-2329 185 10 2013 Jul 09 CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne CMAJ Tinea corporis in a mixed martial arts fighter. 897 10.1503/cmaj.120813 Bachmeyer Claude C Department of Internal Medicine, Tenon Hospital, Paris, France. claude.bachmeyer@tnn.aphp.fr Buot Geneviève G eng Case Reports Journal Article 2012 10 29 Canada CMAJ 9711805 0820-3946 0 Antifungal Agents (...) AIM IM Adult Antifungal Agents therapeutic use Exanthema diagnosis parasitology Humans Male Martial Arts Tinea diagnosis drug therapy transmission Trichophyton 2012 10 31 6 0 2012 10 31 6 0 2013 9 24 6 0 ppublish 23109614 cmaj.120813 10.1503/cmaj.120813 PMC3707996 J Athl Train. 2010 Jul-Aug;45(4):411-28 20617918 Int J Dermatol. 2010 Oct;49(10):1159-64 20636349 Mycoses. 2011 Jul;54(4):e35-8 20002880

2013 CMAJ : Canadian Medical Association Journal PubMed

32. British Association of Dermatologists' guidelines for the management of tinea capitis

British Association of Dermatologists' guidelines for the management of tinea capitis GUIDELINES BJD British Journal of Dermatology British Association of Dermatologists’ guidelines for the management of tinea capitis 2014 L.C. Fuller, 1 R.C. Barton, 2 M.F. Mohd Mustapa, 3 L.E. Proudfoot, 4 S.P. Punjabi 5 and E.M. Higgins 6 1 Department of Dermatology, Chelsea & Westminster Hospital, Fulham Road, London SW10 9NH, U.K. 2 Department of Microbiology, Leeds General In?rmary, Leeds LS1 3EX, U.K. 3 (...) years from May 2010. More information on accreditation, and full details of our accreditation can be viewed at www.nice.org.uk/accreditation. 1.0 Purpose and scope The overall objective of this guideline is to provide up-to- date, evidence-based recommendations for the management of tinea capitis. This document aims to update and expand on the previous guidelines by (i) offering an appraisal of all relevant literature since January 1999, focusing on any key developments; (ii) addressing important

2014 British Association of Dermatologists

33. An Outbreak of Tinea Capitis and Tinea Corporis due to Microsporum Lanosum (Full text)

An Outbreak of Tinea Capitis and Tinea Corporis due to Microsporum Lanosum 13536919 2000 07 01 2018 12 01 0008-4409 78 8 1958 Apr 15 Canadian Medical Association journal Can Med Assoc J An outbreak of tinea capitis and tinea corporis due to Microsporum lanosum. 579-83 BIRT A R AR eng Journal Article Canada Can Med Assoc J 0414110 0008-4409 OM Dermatitis Disease Outbreaks Humans Microsporum Tinea epidemiology Tinea Capitis 5834:29455:527 RINGWORM/epidemiology 1958 4 15 1958 4 15 0 1 1958 4 15 0

1958 Canadian Medical Association Journal PubMed

34. Comparative evaluation of effectivity and safety of topical amorolfine and clotrimazole in the treatment of tinea corporis. (Full text)

Comparative evaluation of effectivity and safety of topical amorolfine and clotrimazole in the treatment of tinea corporis. Tinea corporis is a common superficial dermatophytosis seen in tropical countries. Newer molecules are constantly being introduced for its treatment. Topical clotrimazole is in vogue as the treatment for this condition for a long time. Amorolfine is a comparatively recently introduced drug for topical use in this condition.To assess the effectivity and safety of amorolfine (...) 0.25% cream in patients with tinea corporis, in comparison to clotrimazole 1% cream.Patients presenting with symptoms of tinea corporis were mycologically confirmed for the presence of fungal hyphae. They were randomly divided into two groups: one group received amorolfine and the other received clotrimazole. Treatment duration was for 4 weeks and study duration was for 8 weeks. Evaluation was carried out using the standard clinical parameters on day 1, day 14, day 28 and a follow-up on day 56

2012 Indian journal of dermatology PubMed

35. Tinea Corporis Gladiatorum

Tinea Corporis Gladiatorum Tinea Corporis Gladiatorum Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Tinea Corporis Gladiatorum Tinea (...) Corporis Gladiatorum Aka: Tinea Corporis Gladiatorum From Related Chapters II. Definition variant seen in wrestlers III. Epidemiology Seen in wrestlers from skin-to-skin contact IV. Signs Characteristics Classic s as described above or Erythematous s or s Distribution Head, neck and arms V. Management See VI. Prevention Lesions must be completely and securely covered for wrestlers to participate Wrestlers with extensive involvement may return to sport after one week of treatment VII. References Images

2015 FP Notebook

36. Tinea Corporis

Tinea Corporis Tinea Corporis Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Tinea Corporis Tinea Corporis Aka: Tinea Corporis (...) cases due to hepatotoxicity If is used, requires s at baseline and again weekly X. Complications Deep follicular (Majocchi's Granuloma) Complication of use More commonly affects women, and most often on legs XI. References Gilbert (1999) Sanford Guide to Antimicrobials Images: Related links to external sites (from Bing) These images are a random sampling from a Bing search on the term "Tinea Corporis." Click on the image (or right click) to open the source website in a new browser window. Related

2015 FP Notebook

37. Senna Alata Leaf Decoction as a Treatment for Tinea Imbricata

Society Study Details Study Description Go to Brief Summary: Background: Tinea imbricata ("tokelau") is a rare form of tinea corporis which is caused by Trichophyton concentricum. It is endemic among the T'boli tribe in Sarangani, Philippines . Temporary remissions, despite antifungal treatment, can be attributed to factors such as genetic susceptibility, widespread poverty, poor hygienic conditions and overcrowding. Limited access to commercial antifungal medications makes the treatment of tinea (...) Senna Alata Leaf Decoction as a Treatment for Tinea Imbricata Senna Alata Leaf Decoction as a Treatment for Tinea Imbricata - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Senna Alata Leaf Decoction

2017 Clinical Trials

38. Tinea Corporis (Full text)

Tinea Corporis 20476399 2010 06 24 2010 06 24 0041-6193 22 Suppl 1 1953 May The Ulster medical journal Ulster Med J Tinea Corporis. 34-7 eng Journal Article Northern Ireland Ulster Med J 0417367 0041-6193 2010 5 18 6 0 1953 5 1 0 0 1953 5 1 0 1 ppublish 20476399 PMC2479714

1953 The Ulster medical journal PubMed

39. Unusually Widespread Tinea Corporis (Full text)

Unusually Widespread Tinea Corporis 13658161 2000 07 01 2018 12 01 0035-9157 52 5 1959 May Proceedings of the Royal Society of Medicine Proc. R. Soc. Med. Unusually widespread tinea corporis. 371-2 RIDLEY C M CM eng Case Reports Journal Article England Proc R Soc Med 7505890 0035-9157 OM Dermatitis Humans Medical Records Tinea 5936:32129:474 RINGWORM/case reports 1959 5 1 1959 5 1 0 1 1959 5 1 0 0 ppublish 13658161 PMC1869212

1959 Proceedings of the Royal Society of Medicine PubMed

40. Tinea Corporis

Tinea Corporis Tinea Corporis - Dermatologic Disorders - MSD Manual Professional Edition Brought to you by The trusted provider of medical information since 1899 SEARCH SEARCH MEDICAL TOPICS Common Health Topics Resources QUIZZES & CASES Quizzes Cases The trusted provider of medical information since 1899 SEARCH SEARCH MEDICAL TOPICS Common Health Topics Resources QUIZZES & CASES Quizzes Cases / / / / IN THIS TOPIC OTHER TOPICS IN THIS CHAPTER Test your knowledge Diagnostic Tests for Skin (...) : This is the Professional Version. CONSUMERS: Topic Resources Tinea corporis is a dermatophyte infection of the face, trunk, and extremities. Tinea corporis is a that causes pink-to-red annular (O-shaped) patches and plaques with raised scaly borders that expand peripherally and tend to clear centrally. A rare variant form appears as nummular (circle- or round-shaped) scaling patches studded with small papules or pustules that have no central clearing. Common causes are Trichophyton mentagrophytes, T. rubrum

2013 Merck Manual (19th Edition)

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>